Moderna
MRNA
#1211
Rank
A$24.55 B
Marketcap
$63.80
Share price
-3.36%
Change (1 day)
-58.94%
Change (1 year)
Moderna, Inc. is an American biotechnology company focused on the discovery and development of messenger RNA-based drugs.

P/S ratio for Moderna (MRNA)

P/S ratio as of January 2025 (TTM): 3.05

According to Moderna 's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 1.29. At the end of 2024 the company had a P/S ratio of 5.00.

P/S ratio history for Moderna from 2018 to 2024

PS ratio at the end of each year

Year P/S ratio Change
20245.00-10.96%
20235.6153.56%
20223.66-37.03%
20215.81-96.15%
20201519.95%
2019137235.08%
201840.9

P/S ratio for similar companies or competitors

Company P/S ratio P/S ratio differencediff. Country
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA
3.97 29.90%๐Ÿ‡บ๐Ÿ‡ธ USA
10.4 240.95%๐Ÿ‡บ๐Ÿ‡ธ USA
17.0 457.23%๐Ÿ‡บ๐Ÿ‡ธ USA
4.19 37.10%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
685 22,332.24%๐Ÿ‡บ๐Ÿ‡ธ USA
4.18 36.88%๐Ÿ‡บ๐Ÿ‡ธ USA
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA